Cargando…
Effect of Tocilizumab Treatment on Patients with Coronavirus Disease 2019 and Bacteremia: A Retrospective Cohort Study
INTRODUCTION: This study aimed to determine if tocilizumab treatment for coronavirus disease 2019 (COVID-19) increases bacteremia and suppresses fever and inflammatory reactants. METHODS: In this single-center, retrospective, observational study, all patients with COVID-19 admitted to our emergency...
Autores principales: | Kuwahara, Masaatsu, Kamigaito, Misa, Nitta, Shou, Hasegawa, Kana, Murakami, Hiromoto, Kobayashi, Tomoyuki, Shirai, Kunihiro, Kohama, Keisuke, Hirata, Jun-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775152/ https://www.ncbi.nlm.nih.gov/pubmed/35060111 http://dx.doi.org/10.1007/s40121-022-00592-1 |
Ejemplares similares
-
Prognostic Factors Associated With Mortality of Patients With COVID-19 Requiring Ventilator Management: A Retrospective Cohort Study
por: Kuwahara, Masaatsu, et al.
Publicado: (2022) -
Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
por: Kuwahara, Masaatsu, et al.
Publicado: (2022) -
High Plasma tPAPAI-1C Levels May Be Related to a Poor Prognosis in Patients with Severe or Critical COVID-19: A Single-Center Retrospective Study
por: Shirai, Kunihiro, et al.
Publicado: (2023) -
N95 masks worn to protect against COVID-19 prevented tuberculosis exposure in healthcare workers
por: Kuwahara, Masaatsu, et al.
Publicado: (2022) -
Theophylline Intoxication-Like Signs Despite Normal Serum Concentration in an Older Patient
por: Kuwahara, Masaatsu
Publicado: (2022)